Integra LifeSciences (IART) PT Lowered to $14 at Citi
Citi analyst Joanne Wuensch lowered the price target on Integra LifeSciences (NASDAQ: IART) to $14.00 (from $15.00) while maintaining a Neutral rating.
Citi analyst Joanne Wuensch lowered the price target on Integra LifeSciences (NASDAQ: IART) to $14.00 (from $15.00) while maintaining a Neutral rating.